176 related articles for article (PubMed ID: 17073887)
21. Successful treatment of a facial attack of angioedema with icatibant in a patient with idiopathic angioedema.
Montinaro V; Loizzo G; Zito A; Castellano G; Gesualdo L
Am J Emerg Med; 2013 Aug; 31(8):1295.e5-6. PubMed ID: 23706583
[No Abstract] [Full Text] [Related]
22. Effects of the bradykinin B2 receptor antagonist icatibant on microvascular permeability after thermal injury in sheep.
Jonkam CC; Enkhbaatar P; Nakano Y; Boehm T; Wang J; Nussberger J; Esechie A; Traber LD; Herndon D; Traber DL
Shock; 2007 Dec; 28(6):704-9. PubMed ID: 17607158
[TBL] [Abstract][Full Text] [Related]
23. The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor.
Bellucci F; Meini S; Cucchi P; Catalani C; Giuliani S; Zappitelli S; Rotondaro L; Quartara L; Giolitti A; Maggi CA
Eur J Pharmacol; 2004 May; 491(2-3):121-5. PubMed ID: 15140628
[TBL] [Abstract][Full Text] [Related]
24. The role of icatibant-the B2 bradykinin receptor antagonist-in life-threatening laryngeal angioedema in the ED.
Bartal C; Zeldetz V; Stavi V; Barski L
Am J Emerg Med; 2015 Mar; 33(3):479.e1-3. PubMed ID: 25241359
[TBL] [Abstract][Full Text] [Related]
25. Clinical efficacy of icatibant in the treatment of acute hereditary angioedema during the FAST-3 trial.
Baş M
Expert Rev Clin Immunol; 2012 Nov; 8(8):707-17. PubMed ID: 23167682
[TBL] [Abstract][Full Text] [Related]
26. Nonhistaminergic idiopathic angioedema: clinical response to icatibant.
Colás C; Montoiro R; Fraj J; Garcés M; Cubero JL; Caballero T
J Investig Allergol Clin Immunol; 2012; 22(7):520-1. PubMed ID: 23397675
[No Abstract] [Full Text] [Related]
27. [Hereditary angioedema].
Bouilland O; Schoenlaub P
Rev Prat; 2012 Jan; 62(1):26. PubMed ID: 22335061
[No Abstract] [Full Text] [Related]
28. The bradykinin B2 receptor antagonist icatibant (Hoe 140) blocks aminopeptidase N at micromolar concentrations: off-target alterations of signaling mediated by the bradykinin B1 and angiotensin receptors.
Bawolak MT; Fortin JP; Vogel LK; Adam A; Marceau F
Eur J Pharmacol; 2006 Dec; 551(1-3):108-11. PubMed ID: 17026984
[TBL] [Abstract][Full Text] [Related]
29. Antagonistic effects of novel non-peptide chlorobenzhydryl piperazine compounds on contractile response to bradykinin in the guinea-pig ileum.
Kam YL; Ro JY; Kim HJ; Choo HY
Eur J Pharmacol; 2005 Oct; 523(1-3):143-50. PubMed ID: 16226247
[TBL] [Abstract][Full Text] [Related]
30. Aryl sulfones as novel bradykinin B1 receptor antagonists for treatment of chronic pain.
Biswas K; Aya T; Qian W; Peterkin TA; Chen JJ; Human J; Hungate RW; Kumar G; Arik L; Lester-Zeiner D; Biddlecome G; Manning BH; Sun H; Dong H; Huang M; Loeloff R; Johnson EJ; Askew BC
Bioorg Med Chem Lett; 2008 Sep; 18(17):4764-9. PubMed ID: 18706809
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological characterization of the bradykinin B2 receptor antagonist MEN16132 in rat in vitro bioassays.
Meini S; Cucchi P; Catalani C; Bellucci F; Giuliani S; Santicioli P; Maggi CA
Eur J Pharmacol; 2009 Aug; 615(1-3):10-6. PubMed ID: 19445925
[TBL] [Abstract][Full Text] [Related]
32. Knee osteoarthritis: a role for bradykinin?
Meini S; Maggi CA
Inflamm Res; 2008 Aug; 57(8):351-61. PubMed ID: 18787773
[TBL] [Abstract][Full Text] [Related]
33. Renin-angiotensin system inhibitors and angioedema: anesthetic implications.
Stojiljkovic L
Curr Opin Anaesthesiol; 2012 Jun; 25(3):356-62. PubMed ID: 22552531
[TBL] [Abstract][Full Text] [Related]
34. Successful treatment of ACE inhibitor-induced angioedema with icatibant, a bradykinin B2 receptor antagonist.
Pucar PA; O'Sullivan M; Goudie A; Marr T; Brusch A
Med J Aust; 2015 Jun; 202(11):596-7. PubMed ID: 26068694
[No Abstract] [Full Text] [Related]
35. Two cases of severe angio-oedema and rationale for their response to icatibant.
Akinduro OO; Patel V; Thomas T; Ahmad FU
BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26678695
[No Abstract] [Full Text] [Related]
36. A fluorescent version of the bradykinin B2 receptor antagonist B-9430: pharmacological characterization and use in live cell imaging.
Bawolak MT; Gera L; Bouthillier J; Stewart JM; Adam A; Marceau F
Peptides; 2008 Sep; 29(9):1626-30. PubMed ID: 18565624
[TBL] [Abstract][Full Text] [Related]
37. Role of substance P and bradykinin in acute pancreatitis induced by secretory phospholipase A2.
Camargo EA; Ferreira T; Ribela MT; de Nucci G; Landucci EC; Antunes E
Pancreas; 2008 Jul; 37(1):50-5. PubMed ID: 18580444
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of drugs-associated non-hereditary angioedema mediated by bradykinin].
Muller Y; Harr T
Rev Med Suisse; 2016 Jan; 12(500):11-2. PubMed ID: 26946694
[TBL] [Abstract][Full Text] [Related]
39. Effect of Intra-articular 4-(S)-amino-5-(4-{4-[2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido]-tetrahydro-2H-4-pyranylcarbonyl} piperazino)-5-oxopentyl](trimethyl)ammonium chloride hydrochloride (MEN16132), a kinin B2 receptor antagonist, on nociceptive response in monosodium iodoacetate-induced experimental osteoarthritis in rats.
Cialdai C; Giuliani S; Valenti C; Tramontana M; Maggi CA
J Pharmacol Exp Ther; 2009 Dec; 331(3):1025-32. PubMed ID: 19745108
[TBL] [Abstract][Full Text] [Related]
40. Nonallergic angioedema: role of bradykinin.
Bas M; Adams V; Suvorava T; Niehues T; Hoffmann TK; Kojda G
Allergy; 2007 Aug; 62(8):842-56. PubMed ID: 17620062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
